Main menu

  • HOME
  • > JSSX Certified Subject Matter Expert (JSSX SME) System

JSSX Certified Subject Matter Expert (JSSX SME) System

Outline of the System

 The Japanese Society for the Study of Xenobiotics (JSSX) has established the JSSX Subject Matter Expert (JSSX SME) System, which is a system for training personnel to study pharmacokinetic theory, share new knowledge, and actively utilize this knowledge in the field of medicine and healthcare. The JSSX SME program recognizes regular members (excluding delegates), who are mainly affiliated with companies, etc., and who have continuously achieved research results or studied in the Society as pharmacokinetic researchers, and awards them the title of JSSX SME. Applications are accepted once a year in conjunction with the open call for delegates.

SME Awardees (as of June 2025)

name Affiliation Field of Specialization
Daigo Asano Daiichi Sankyo Company, Limited Absorption, Drug metabolism enzymes, Pharmacokinetics/ pharmacodynamics
Shinsuke Uchihashi Maruho Co. Bioanalysis, Drug metabolism enzymes
Yasuhiro Ohno Taiho Pharmaceutical Co. Drug-drug interaction, Modeling and simulation
Miho Kazui Daiichi Sankyo Company, Limited Drug metabolism enzymes, Protein binding
Tsuyoshi Karibe Daiichi Sankyo Company, Limited Biologics, Modeling and simulation, Pharmacokinetics/ pharmacodynamics
Takashi Kitaguchi Nissin Foods Holdings Co. Absorption, Toxicology
Saori Ko Asahi Kasei Pharma Corporation Bioanalysis, Drug-drug interaction
Kentaro Konishi Astellas Pharma Inc. Modeling and simulation
Katsunori Sasahara Otsuka Pharmaceutical Co. AI, Biomarkers, In silico analysis
Masakazu Shibata Otsuka Pharmaceutical Co. In vitro-in vivo extrapolation/ prediction, Modeling and simulation, Regulatory science
Koichi Takahashi Taiho Pharmaceutical Co. Clinical pharmacokinetics, Pharmacometrics, Transporters
Tsuyoshi Takahashi Mitsubishi Tanabe Pharma Corporation Drug-drug interaction, Transporters
Koji Tanaka Mitsubishi Tanabe Pharma Corporation Bioanalysis, Imaging, Metabolite identification
Yoko Nagai Daiichi Sankyo Company, Limited Pharmacokinetics/ pharmacodynamics
Miho Nagayasu Chugai Pharmaceutical Co. Animal experiments, Imaging, Pharmacokinetics/ pharmacodynamics
Miyu Nakayama Takeda Pharmaceutical Company Limited Animal experiments, Bioanalysis, Imaging
Eriko Higashi Toray Industries, Inc. Drug metabolism enzymes
Tomoyo Honda Daiichi Sankyo Company, Limited 3. Bioanalysis, Drug-drug interaction, Drug metabolism enzymes
Norikazu Matsunaga Biogen Japan K.K. Clinical pharmacokinetics, In vitro-in vivo extrapolation/ prediction, Pharmacogenetics
Tatsuki Mochizuki Chugai Pharmaceutical Co. Absorption, In vitro-in vivo extrapolation/ prediction, Modeling and simulation
Miki Yokoyama Daiichi Sankyo Company, Limited Biologics, Nucleic acid medicine
Kosuke Yoshida Mitsubishi Tanabe Pharma Corporation Modeling and simulation, Pharmacokinetics/ pharmacodynamics, Pharmacometrics

Significance of the JSSX SME Certification System

  • This is a system to certify mainly corporate researchers who are active in the society as a society.
  • The chairperson and executive committee members of the Corporate Rising Talents Initiative Session (CoRTIS), an exchange program for young corporate researchers organized by the JSSX, are selected from SME-qualified individuals. In principle, SME-qualified participants will also be given priority (the above will be enforced after the SME system is established).